Evidence map›Paper›PMID 27572329›Full record

ArticleInfection and immunity2016

Ehrlichia chaffeensis TRP32 is a Nucleomodulin that Directly Regulates Expression of Host Genes Governing Differentiation and Proliferation.

Tierra R Farris, Paige S Dunphy, Bing Zhu, Clayton E Kibler, Jere W McBride

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 27 citations in OpenAlex.

  1. Type 1 secretion system and effectors in Rickettsiales.Frontiers in cellular and infection microbiology · 2023
    Review
  2. mBio · 2021
    Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Frontiers in immunology · 2021
    Review
  8. Article
  9. Article
  10. Review
  11. Frontiers in microbiology · 2020
    Article
  12. Review
  13. mSphere · 2018
    Article
  14. Article
  15. Article
  16. Frontiers in cellular and infection microbiology · 2017
    Article
  17. Frontiers in cellular and infection microbiology · 2017
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Tierra R FarrisDepartments of Microbiology and Immunology and Pathology.ORCID 0000-0001-9022-1584
Paige S DunphyDepartments of Microbiology and Immunology and Pathology.
Bing ZhuDepartments of Microbiology and Immunology and Pathology.
Clayton E KiblerDepartments of Microbiology and Immunology and Pathology.
Jere W McBrideDepartments of Microbiology and Immunology and Pathology Departments of Microbiology and Immunology and Pathology Center for Biodefense and Emerging Infectious Diseases Sealy Center for Vaccine Development Institute for Human Infections and Immunity , University of Texas Medical Branch, Galveston, TX jemcbrid@utmb.edu.
The University of Texas Medical Branch at Galveston · US

Funding

EMERGING AND TROPICAL INFECTIOUS DISEASEST32AI007526 · NIAID · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI SOONG, LYNN · 1997 to 2025
$3.1M
Ehrlichia T1S Effector Regulation of Host Gene TranscriptionR01AI106859 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI MCBRIDE, JERE W · 2014 to 2017
$1.5M
Ehrlichia Type-1 Secreted Effectors Exploit Host SUMO PathwaysR21AI105536 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI MCBRIDE, JERE W · 2013 to 2014
$421k
NIAID NIH HHS R01 AI106859NIAID NIH HHS R21 AI105536NIAID NIH HHS T32 AI007526
6 · The paper itself

Abstract

Ehrlichia chaffeensis is an obligately intracellular bacterium that reprograms the mononuclear phagocyte through diverse effector-host interactions to modulate numerous host cell processes, including transcription. In a previous study, we reported that E. chaffeensis TRP32, a type 1 secreted effector, interacts with multiple host nucleus-associated proteins and also auto-activates reporter gene expression in yeast. In this study, we demonstrate that TRP32 is a nucleomodulin that binds host DNA and alters host gene transcription. TRP32 enters the host cell nucleus via a noncanonical translocation mechanism that involves phosphorylation of Y179 located in a C-terminal tri-tyrosine motif. Both genistein and mutation of Y179 inhibited TRP32 nuclear entry. An electromobility shift assay (EMSA) demonstrated TRP32 host DNA binding via its tandem repeat domain. TRP32 DNA binding and motif preference were further confirmed by supershift assays, as well as competition and mutant probe analyses. Using ChIP-Seq, we determined that TRP32 binds a G-rich motif primarily within ±500 bp of the gene transcription start site. An ontology analysis identified genes involved in processes such as immune cell differentiation, chromatin remodeling, and RNA transcription and processing, as primary TRP32 targets. TRP32 bound genes (n=1223) were distributed on all chromosomes and included several global regulators of proliferation and inflammation such as FOS and JUN, AKT3 and NRAS, and non-coding RNA genes, miRNA 21 and miRNA 142. TRP32 target genes were differentially regulated during infection, the majority of which were repressed, and direct repression/activation of these genes by TRP32 was confirmed in vitro with a cellular luciferase reporter assay.

Identifiers

PMID27572329
PMCPMC5067751
OpenAlexW2517304634

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.